Using Psychological Artificial Intelligence (Tess) to Relieve Symptoms of Depression and Anxiety: Randomized Controlled Trial
- PMID: 30545815
- PMCID: PMC6315222
- DOI: 10.2196/mental.9782
Using Psychological Artificial Intelligence (Tess) to Relieve Symptoms of Depression and Anxiety: Randomized Controlled Trial
Abstract
Background: Students in need of mental health care face many barriers including cost, location, availability, and stigma. Studies show that computer-assisted therapy and 1 conversational chatbot delivering cognitive behavioral therapy (CBT) offer a less-intensive and more cost-effective alternative for treating depression and anxiety. Although CBT is one of the most effective treatment methods, applying an integrative approach has been linked to equally effective posttreatment improvement. Integrative psychological artificial intelligence (AI) offers a scalable solution as the demand for affordable, convenient, lasting, and secure support grows.
Objective: This study aimed to assess the feasibility and efficacy of using an integrative psychological AI, Tess, to reduce self-identified symptoms of depression and anxiety in college students.
Methods: In this randomized controlled trial, 75 participants were recruited from 15 universities across the United States. All participants completed Web-based surveys, including the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and Positive and Negative Affect Scale (PANAS) at baseline and 2 to 4 weeks later (T2). The 2 test groups consisted of 50 participants in total and were randomized to receive unlimited access to Tess for either 2 weeks (n=24) or 4 weeks (n=26). The information-only control group participants (n=24) received an electronic link to the National Institute of Mental Health's (NIMH) eBook on depression among college students and were only granted access to Tess after completion of the study.
Results: A sample of 74 participants completed this study with 0% attrition from the test group and less than 1% attrition from the control group (1/24). The average age of participants was 22.9 years, with 70% of participants being female (52/74), mostly Asian (37/74, 51%), and white (32/74, 41%). Group 1 received unlimited access to Tess, with daily check-ins for 2 weeks. Group 2 received unlimited access to Tess with biweekly check-ins for 4 weeks. The information-only control group was provided with an electronic link to the NIMH's eBook. Multivariate analysis of covariance was conducted. We used an alpha level of .05 for all statistical tests. Results revealed a statistically significant difference between the control group and group 1, such that group 1 reported a significant reduction in symptoms of depression as measured by the PHQ-9 (P=.03), whereas those in the control group did not. A statistically significant difference was found between the control group and both test groups 1 and 2 for symptoms of anxiety as measured by the GAD-7. Group 1 (P=.045) and group 2 (P=.02) reported a significant reduction in symptoms of anxiety, whereas the control group did not. A statistically significant difference was found on the PANAS between the control group and group 1 (P=.03) and suggests that Tess did impact scores.
Conclusions: This study offers evidence that AI can serve as a cost-effective and accessible therapeutic agent. Although not designed to appropriate the role of a trained therapist, integrative psychological AI emerges as a feasible option for delivering support.
Trial registration: International Standard Randomized Controlled Trial Number: ISRCTN61214172; https://doi.org/10.1186/ISRCTN61214172.
Keywords: anxiety; artificial intelligence; depression; mental health services; students.
©Russell Fulmer, Angela Joerin, Breanna Gentile, Lysanne Lakerink, Michiel Rauws. Originally published in JMIR Mental Health (http://mental.jmir.org), 13.12.2018.
Conflict of interest statement
Conflicts of Interest: AJ and MR are employees of X2AI Inc that created the intervention (Tess) that was used in this trial and, therefore, have financial interest in that company. X2AI Inc covered the cost of participant incentives.
Figures
Similar articles
-
Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial.JMIR Ment Health. 2017 Jun 6;4(2):e19. doi: 10.2196/mental.7785. JMIR Ment Health. 2017. PMID: 28588005 Free PMC article.
-
Using AI chatbots to provide self-help depression interventions for university students: A randomized trial of effectiveness.Internet Interv. 2022 Jan 6;27:100495. doi: 10.1016/j.invent.2022.100495. eCollection 2022 Mar. Internet Interv. 2022. PMID: 35059305 Free PMC article.
-
Feasibility and impact of a mental health chatbot on postpartum mental health: a randomized controlled trial.AJOG Glob Rep. 2023 Mar 29;3(3):100165. doi: 10.1016/j.xagr.2023.100165. eCollection 2023 Aug. AJOG Glob Rep. 2023. PMID: 37560011 Free PMC article.
-
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT.Southampton (UK): NIHR Journals Library; 2019 Dec. Southampton (UK): NIHR Journals Library; 2019 Dec. PMID: 31869013 Free Books & Documents. Review.
-
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.Cochrane Database Syst Rev. 2015 Mar 5;(3):CD011565. doi: 10.1002/14651858.CD011565. Cochrane Database Syst Rev. 2015. PMID: 25742186 Updated. Review.
Cited by
-
Clinical Practice Guidelines on using artificial intelligence and gadgets for mental health and well-being.Indian J Psychiatry. 2024 Jan;66(Suppl 2):S414-S419. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_926_23. Epub 2024 Jan 24. Indian J Psychiatry. 2024. PMID: 38445270 Free PMC article. No abstract available.
-
Attrition in Conversational Agent-Delivered Mental Health Interventions: Systematic Review and Meta-Analysis.J Med Internet Res. 2024 Feb 27;26:e48168. doi: 10.2196/48168. J Med Internet Res. 2024. PMID: 38412023 Free PMC article. Review.
-
Demographic and clinical characteristics associated with anxiety and depressive symptom outcomes in users of a digital mental health intervention incorporating a relational agent.BMC Psychiatry. 2024 Jan 30;24(1):79. doi: 10.1186/s12888-024-05532-6. BMC Psychiatry. 2024. PMID: 38291369 Free PMC article.
-
Psychoeducation for adult ADHD: a scoping review about characteristics, patient involvement, and content.BMC Psychiatry. 2024 Jan 25;24(1):73. doi: 10.1186/s12888-024-05530-8. BMC Psychiatry. 2024. PMID: 38273266 Free PMC article. Review.
-
Barriers and facilitators to the implementation of family cancer history collection tools in oncology clinical practices.J Am Med Inform Assoc. 2024 Feb 16;31(3):631-639. doi: 10.1093/jamia/ocad243. J Am Med Inform Assoc. 2024. PMID: 38164994
References
-
- Snyder T. de Brey C. Dillow S . Nces.ed. National center for education statistics; 2016. Dec 08, [2017-03-01]. Digest of Education Statistics https://nces.ed.gov/programs/digest/d15/tables/dt15_105.20.asp?current=yes,
-
- Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011 Feb;31(1):89–103. doi: 10.1016/j.cpr.2010.09.008.S0272-7358(10)00166-2 - DOI - PubMed
-
- Warmerdam L, Smit F, van Straten A, Riper H, Cuijpers P. Cost-utility and cost-effectiveness of internet-based treatment for adults with depressive symptoms: randomized trial. J Med Internet Res. 2010;12(5):e53. doi: 10.2196/jmir.1436. http://www.jmir.org/2010/5/e53/ v12i5e53 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
